Ocular Tissue Distribution of Topically Applied PEGylated and Non-PEGylated Liposomes

Abstract:

Topical ocular drug delivery has always been a challenging area due to poor ocular bioavailability. Improved drug delivery systems such as liposomes are capable of entrapping both the lipophilic and hydrophilic substances. Therefore, they are effective formulations for drug delivery to targeted structure. PEGylated-liposomes are known to have stealth properties due to their ability of resisting removal by phagocytic cells. This study compares ability of PEGylated-and nonPEGylated-liposomes in delivering lipophilic fluorescent dye, Dil, to several ocular tissues. Sprague-Dawley rats (190-250g) were divided into 2 groups that received unilateral topical application of single drop of PEGylated-liposome (PEG-Lip) or nonPEGylated-liposome (Lip). Contralateral eyes served as control and received no treatment. Animals were sacrificed at several time points, post-instillation, and eyeballs were enucleated. Cryostat sectioning was done and sections were viewed with fluorescence microscope. Fluorescence intensity (FI) was calculated and quantified. In treated eyes, nonPEGylated-liposomes showed faster corneal permeation compared to PEGylated-liposomes. NonPEGylated-liposomes also showed faster availability in ciliary body and retina of treated eyes, possibly a consequence of faster corneal permeation. Their higher engulfment by macrophages and subsequent localization in vascular tissue may also be a contributing factor. In contralateral eyes, both groups showed dye distribution indicating their significant systemic distribution. Higher availability of non-PEGylated-liposomes in contralateral eyes also indicated that they are more likely to undergo phagocytosis and consequently faster removal. In conclusion, PEG-lip showed slower corneal permeation in the treated eyes. Both types of liposomes undergo significant systemic absorption. Since, PEG-lip are more resistant to phagocytosis, they may provide more sustained drug delivery.

• Periodical: Advanced Materials Research (Volume 832)
• Pages: 1-8
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.832.1
• Online since: November 2013
• Authors: Nurul Alimah Abdul Nasir, Renad Nikolaevich Alyautdin, Renu Agarwal, Natalia Nukolova, Vladimir Cheknonin, Nafeeza Mohd Ismail
• Keywords: Fluorescent, Lipophilic, Liposomes, Ocular Drug Delivery, PEGylated

References

[1] N.M. Davies, Biopharmaceutical considerations in topical ocular drug delivery, Clin. Exp. Pharmacol. P., 27 (2001) 558-562.

DOI: 10.1046/j.1440-1681.2000.03288.x

[2] I. P. Kaur, A. Garg, A. K. Singla, & D. Aggarwal, Vesicular systems in ocular drug delivery: an overview, Int. J. Pharm., 269 (2004) 1-14.

DOI: 10.1016/j.ijpharm.2003.09.016

[3] R. Gaudana, H.K. Ananthula, A. Parenky, & A. K. Mitra, Ocular drug delivery, AAPS J., 12 (2010) 348-360.

DOI: 10.1208/s12248-010-9183-3

[4] T. Loftsson, D. Hreinsdóttir, & E. Stefansson, Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. J. Pharm. Pharmacol., 59 (2007) 629-635.

DOI: 10.1211/jpp.59.5.0002

[5] Y. Inokuchi, K. Hironaka, T. Fujisawa, Y. Tozuka, K. Tsuruma, M. Shimazawa,...& H. Hara, Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration, Invest. Ophth. Vis. Sci., 51 (2010) 3162-3170.

DOI: 10.1167/iovs.09-4697

[6] J. Araújo, S. Nikolic, M.A. Egea, E B. Souto, & M.L. Garcia, Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye, Colloids Surf., B., 88 (2011) 150-157.

DOI: 10.1016/j.colsurfb.2011.06.025

[7] H. Shimazaki, K. Hironaka, T. Fujisawa, K. Tsuruma, Y. Tozuka, M. Shimazawa,...& H. Hara, Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice, Invest. Ophth. Vis. Sci., 52 (2011) 7289-7297.

DOI: 10.1167/iovs.11-7983

[8] H. Sasaki, K. Karasawa, K. Hironaka, K. Tahara, Y. Tozuka, & H. Takeuchi, Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes, Eur. J. Pharm. Biopharm., (2012) Article in press

DOI: 10.1016/j.ejpb.2012.10.014

[9] G. Smolin, M. Okumoto, S. Feiler, & D. Condon, Idoxuridine-liposome therapy for herpes simplex keratitis, Am. J. Ophthalmol., 91 (1981), 220.

DOI: 10.1016/0002-9394(81)90177-x

[10] H.E. Schaeffer, & D.L. Krohn, Liposomes in topical drug delivery, Invest. Ophth. Vis. Sci., 22 (1982) 220-227.

[11] L.S.S. Guo, C.T. Redmann, & R. Radhakrishnan, Bioadhesive liposomes in ophthalmic drug delivery, Invest. Ophth. Vis. Sci., 28 (1987) 72.

[12] N.M. Davies, S.J. Farr, J. Hadgraft, & I.W. Kellaway, Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles, Pharmaceut. Res., 9 (1992) 1137-1144.

[13] P. Calvo, J.L. Vila-Jato, & M.J. Alonso, Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers, Int. J. Pharm., 153 (1997) 41-50.

DOI: 10.1016/s0378-5173(97)00083-5

[14] R. Cortesi, R, Argnani, E. Esposito, A. Dalpiaz, A. Scatturin, F, Bortolotti,...& R. Manservigi, Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity, Int. J.Pharm., 317 (2006) 90-100.

DOI: 10.1016/j.ijpharm.2006.02.050

[15] M.C. Woodle & D.D. Lasic, Sterically stabilized liposomes, Biochim. Biophys. Acta, 1113 (1992) 171.

[16] P.G. McMenamin, The distribution of immune cells in the uveal tract of the normal eye, Eye, 11 (1997) 183-193.

DOI: 10.1038/eye.1997.49

[17] P. Yang, A.F. De Vos, & A. Kijlstra, Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide, Invest. Ophth. Vis. Sci., 37 (1996) 77-85.

[18] S.M. Moghimi, A.C. Hunter, & J.C Murray, Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol. Rev., 53 (2001) 283-318.

[19] S.M. Moghimi & J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties, Prog. Lipid Res., 42 (2003) 463-478.

DOI: 10.1016/s0163-7827(03)00033-x